Polymyositis Market Report 2026
Download Free Sample Buy Now
Polymyositis Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Polymyositis Market Report 2026

Global Outlook – By Type (Idiopathic Polymyositis, Dermatomyositis, Inclusion Body Myositis, Overlapping Myositis Syndromes), By Diagnosis (Physical Examination, Muscle Biopsy, Electromyography (EMG), Blood Tests, Magnetic Resonance Imaging (MRI)), By Treatment (Immunosuppressant, Immunoglobulins, Corticosteroids, Alkylating agents, Monoclonal Antibodies), By Distribution Channel (Offline, Online), By End User (Hospital pharmacy, Online pharmacy, Retail pharmacy) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Polymyositis Market Overview

• Polymyositis market size has reached to $1.74 billion in 2025

• Expected to grow to $2.34 billion in 2030 at a compound annual growth rate (CAGR) of 6%

• Growth Driver: Rising Prevalence Of Autoimmune Diseases Driving Growth In The Market Due To Increasing Diagnosis Rates And Advancements In Treatment Options

• Market Trend: Advancements In Stem Cell Therapy For Autoimmune Diseases

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Polymyositis Market?

Polymyositis is a chronic inflammatory myopathy characterized by progressive muscle weakness, primarily affecting the skeletal muscles. It results from an autoimmune response where the body's immune system mistakenly attacks muscle fibers, leading to inflammation, degeneration, and weakness.

The main types of polymyositis are idiopathic polymyositis, dermatomyositis, inclusion body myositis, and overlapping myositis syndromes. Idiopathic polymyositis is a rare muscle disease that causes weakness and inflammation and is treated with corticosteroids. It is diagnosed through various methods, including physical examination, muscle biopsy, electromyography (EMG), blood tests, and magnetic resonance imaging (MRI). Treatments for the condition include immunosuppressants, immunoglobulins, corticosteroids, alkylating agents, monoclonal antibodies, and other drugs. These treatments are distributed through various channels, such as offline, online, and are used by different end users, including hospital pharmacies, online pharmacies, and retail pharmacies.

Polymyositis Market Global Report 2026 Market Report bar graph

What Is The Polymyositis Market Size and Share 2026?

The polymyositis market size has grown strongly in recent years. It will grow from $1.74 billion in 2025 to $1.85 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to improved understanding of autoimmune myopathies, availability of muscle biopsy diagnostics, increased use of corticosteroids, expansion of hospital diagnostic capabilities, rising identification of rare muscle disorders.

What Is The Polymyositis Market Growth Forecast?

The polymyositis market size is expected to see strong growth in the next few years. It will grow to $2.34 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to growing development of targeted immune therapies, increasing integration of precision diagnostics, rising use of biologics and immunoglobulins, expansion of personalized treatment strategies, growing research into autoimmune disease mechanisms. Major trends in the forecast period include increasing use of immunosuppressive therapies, rising adoption of monoclonal antibody treatments, growing focus on accurate differential diagnosis, expansion of advanced diagnostic imaging, enhanced patient monitoring protocols.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Polymyositis Market Segmentation

1) By Type: Idiopathic Polymyositis, Dermatomyositis, Inclusion Body Myositis, Overlapping Myositis Syndromes

2) By Diagnosis: Physical Examination, Muscle Biopsy, Electromyography (EMG), Blood Tests, Magnetic Resonance Imaging (MRI)

3) By Treatment: Immunosuppressant, Immunoglobulins, Corticosteroids, Alkylating agents, Monoclonal Antibodies

4) By Distribution Channel: Offline, Online

5) By End User: Hospital pharmacy, Online pharmacy, Retail pharmacy

Subsegments:

1) By Idiopathic Polymyositis: Immune-Mediated Polymyositis, Virus-Associated Polymyositis

2) By Dermatomyositis: Classic Dermatomyositis, Amyopathic Dermatomyositis, Juvenile Dermatomyositis

3) By Inclusion Body Myositis: Sporadic Inclusion Body Myositis, Hereditary Inclusion Body Myopathy

4) By Overlapping Myositis Syndromes:Polymyositis with Systemic Lupus Erythematosus (SLE), Polymyositis with Rheumatoid Arthritis (RA), Polymyositis with Systemic Sclerosis, Polymyositis with Mixed Connective Tissue Disease (MCTD)

What Are The Drivers Of The Polymyositis Market?

The increasing prevalence of autoimmune diseases is expected to propel the growth of the polymyositis market going forward. Autoimmune diseases refer to medical conditions in which the body's immune system mistakenly attacks its own healthy cells, tissues, or organs, leading to inflammation and damage. The prevalence of autoimmune diseases is increasing as certain genetic variants can lead to an overactive immune response, making individuals more susceptible to mistakenly attacking their own tissues. This genetic susceptibility, combined with environmental triggers such as infections, stress, and lifestyle factors, contributes to the rising incidence of autoimmune conditions. Polymyositis enhances the understanding of autoimmune diseases by demonstrating how immune system dysfunction leads to muscle inflammation, offering insights into underlying mechanisms and potential treatments for related conditions. For instance, in February 2024, according to Arthritis Australia, an Australia-based charitable not-for-profit organisation advocating for people with arthritis and musculoskeletal conditions, by 2025, approximately 562,378 Australians are living with rheumatoid arthritis (RA), accounting for 14% of the total arthritis population. Therefore, the increasing prevalence of autoimmune diseases is driving the Polymyositis industry.

The rising demand for oral drugs is expected to propel the growth of the polymyositis market going forward. Oral drugs refer to medications that are taken by mouth in the form of tablets, capsules, or liquids and are absorbed through the digestive system. The rising demand for oral drugs is attributed to their convenience, ease of administration, and patient preference for non-invasive treatments, which makes them a preferred choice over injections or other delivery methods. Polymyositis is treated with oral drugs that help reduce muscle inflammation, modulate the immune system, and enhance muscle function, thereby alleviating symptoms and preventing disease progression. For instance, in October 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government administration, among 393,390 non-hospitalized U.S. adults aged 65 years and older, 45.9% received an oral antiviral treatment (nirmatrelvir-ritonavir or molnupiravir) within 30 days of diagnosis, with usage reported at 48.4% for individuals aged 65–74 years and 35.2% for those aged 90 years and above. Therefore, the rising demand for oral drugs is driving the growth of the polymyositis industry.

Key Players In The Global Polymyositis Market

Major companies operating in the polymyositis market are Pfizer Inc., F Hoffmann La Roche AG, Bristol Myers Squibb Company, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Merck & Co. Inc., C H Boehringer Sohn AG & Co. KG, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Fresenius SE & Co. KGaA, UCB S.A., Teva Pharmaceuticals USA Inc., Kezar Life Sciences Inc., Argenx SE, Mallinckrodt Pharmaceuticals plc, Mitsubishi Tanabe Pharma Corporation, Sanofi S.A., AbbVie Inc., Eli Lilly and Company, Janssen Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., CSL Behring

Global Polymyositis Market Trends and Insights

Major companies operating in the polymyositis market are focusing on developing innovative therapies such as stem cell therapy to enhance treatment efficacy and slow disease progression. Stem cell therapy involves the use of umbilical cord-derived stem cells for regenerative treatment. These stem cells have strong immunomodulatory and anti-inflammatory properties, making them a promising option for treating autoimmune diseases such as polymyositis. For instance, in December 2024, RESTEM, a US-based clinical-stage biotechnology company, received Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA) for its stem cell program utilizing umbilical cord outer lining stem cells (ULSCs). This program utilizes umbilical cord outer lining stem cells to treat polymyositis and Dermatomyositis by regulating the immune system and reducing muscle inflammation. The therapy has shown promising safety and efficacy in early trials, with potential to decrease steroid dependency.

Need data on a specific region in this market?
Request Regional Data

Regional Outlook

North America was the largest region in the polymyositis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Polymyositis Market?

The polymyositis market consists of revenues earned by entities by providing services such as diagnosis and testing services, pharmacological treatment services, physical therapy and rehabilitation services, and occupational therapy services. The market value includes the value of related goods sold by the service provider or included within the service offering. The polymyositis market also includes sales of anti-inflammatory and pain management medications, biologic therapies, intravenous immunoglobulin (IVIG) therapy, and plasmapheresis (plasma exchange) products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Polymyositis Market Report 2026?

The polymyositis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the polymyositis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Polymyositis Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.85 billion
Revenue Forecast In 2035 $2.34 billion
Growth Rate CAGR of 6.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Diagnosis, Treatment, Distribution Channel, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., F Hoffmann La Roche AG, Bristol Myers Squibb Company, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Merck & Co. Inc., C H Boehringer Sohn AG & Co. KG, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Fresenius SE & Co. KGaA, UCB S.A., Teva Pharmaceuticals USA Inc., Kezar Life Sciences Inc., Argenx SE, Mallinckrodt Pharmaceuticals plc, Mitsubishi Tanabe Pharma Corporation, Sanofi S.A., AbbVie Inc., Eli Lilly and Company, Janssen Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., CSL Behring
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Polymyositis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Polymyositis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Polymyositis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Polymyositis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Use Of Immunosuppressive Therapies

4.2.2 Rising Adoption Of Monoclonal Antibody Treatments

4.2.3 Growing Focus On Accurate Differential Diagnosis

4.2.4 Expansion Of Advanced Diagnostic Imaging

4.2.5 Enhanced Patient Monitoring Protocols

5. Polymyositis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Neurology Clinics

5.3 Rheumatology Clinics

5.4 Diagnostic Centers

5.5 Specialty Pharmacies

6. Polymyositis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Polymyositis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Polymyositis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Polymyositis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Polymyositis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Polymyositis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Polymyositis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Polymyositis Market Segmentation

9.1. Global Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Idiopathic Polymyositis, Dermatomyositis, Inclusion Body Myositis, Overlapping Myositis Syndromes

9.2. Global Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Physical Examination, Muscle Biopsy, Electromyography (EMG), Blood Tests, Magnetic Resonance Imaging (MRI)

9.3. Global Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunosuppressant, Immunoglobulins, Corticosteroids, Alkylating agents, Monoclonal Antibodies

9.4. Global Polymyositis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Offline, Online

9.5. Global Polymyositis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital pharmacy, Online pharmacy, Retail pharmacy

9.6. Global Polymyositis Market, Sub-Segmentation Of Idiopathic Polymyositis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immune-Mediated Polymyositis, Virus-Associated Polymyositis

9.7. Global Polymyositis Market, Sub-Segmentation Of Dermatomyositis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Classic Dermatomyositis, Amyopathic Dermatomyositis, Juvenile Dermatomyositis

9.8. Global Polymyositis Market, Sub-Segmentation Of Inclusion Body Myositis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sporadic Inclusion Body Myositis, Hereditary Inclusion Body Myopathy

9.9. Global Polymyositis Market, Sub-Segmentation Of Overlapping Myositis Syndromes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymyositis with Systemic Lupus Erythematosus (SLE), Polymyositis with Rheumatoid Arthritis (RA), Polymyositis with Systemic Sclerosis, Polymyositis with Mixed Connective Tissue Disease (MCTD)

10. Polymyositis Market Regional And Country Analysis

10.1. Global Polymyositis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Polymyositis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Polymyositis Market

11.1. Asia-Pacific Polymyositis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Polymyositis Market

12.1. China Polymyositis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Polymyositis Market

13.1. India Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Polymyositis Market

14.1. Japan Polymyositis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Polymyositis Market

15.1. Australia Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Polymyositis Market

16.1. Indonesia Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Polymyositis Market

17.1. South Korea Polymyositis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Polymyositis Market

18.1. Taiwan Polymyositis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Polymyositis Market

19.1. South East Asia Polymyositis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Polymyositis Market

20.1. Western Europe Polymyositis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Polymyositis Market

21.1. UK Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Polymyositis Market

22.1. Germany Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Polymyositis Market

23.1. France Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Polymyositis Market

24.1. Italy Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Polymyositis Market

25.1. Spain Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Polymyositis Market

26.1. Eastern Europe Polymyositis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Polymyositis Market

27.1. Russia Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Polymyositis Market

28.1. North America Polymyositis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Polymyositis Market

29.1. USA Polymyositis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Polymyositis Market

30.1. Canada Polymyositis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Polymyositis Market

31.1. South America Polymyositis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Polymyositis Market

32.1. Brazil Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Polymyositis Market

33.1. Middle East Polymyositis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Polymyositis Market

34.1. Africa Polymyositis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Polymyositis Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Polymyositis Market Regulatory and Investment Landscape

36. Polymyositis Market Competitive Landscape And Company Profiles

36.1. Polymyositis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Polymyositis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Polymyositis Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F Hoffmann La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Polymyositis Market Other Major And Innovative Companies

GlaxoSmithKline plc, Merck & Co. Inc., C H Boehringer Sohn AG & Co. KG, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Fresenius SE & Co. KGaA, UCB S.A., Teva Pharmaceuticals USA Inc., Kezar Life Sciences Inc., Argenx SE, Mallinckrodt Pharmaceuticals plc, Mitsubishi Tanabe Pharma Corporation, Sanofi S.A., AbbVie Inc., Eli Lilly and Company

38. Global Polymyositis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Polymyositis Market

40. Polymyositis Market High Potential Countries, Segments and Strategies

40.1 Polymyositis Market In 2030 - Countries Offering Most New Opportunities

40.2 Polymyositis Market In 2030 - Segments Offering Most New Opportunities

40.3 Polymyositis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Polymyositis Market, Overview Of Key Products - Product Examples
  • Table 2: Global Polymyositis Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Polymyositis Market, Supply Chain Analysis
  • Table 4: Global Polymyositis Market, Major Raw Material Providers
  • Table 5: Global Polymyositis Market, Major Resource Providers
  • Table 6: Global Polymyositis Market, Major Manufacturers (Suppliers)
  • Table 7: Global Polymyositis Market, Major Distributors And Channel Partners
  • Table 8: Global Polymyositis Market, Key Technologies & Future Trends
  • Table 9: Global Polymyositis Market, Major Trends
  • Table 10: Global Polymyositis Market, Major End Users
  • Table 11: Global Polymyositis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Polymyositis Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Polymyositis Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Polymyositis Market - TAM, US$ Billion, 2025
  • Table 15: Global Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Polymyositis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Polymyositis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Polymyositis Market, Sub-Segmentation Of Idiopathic Polymyositis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Polymyositis Market, Sub-Segmentation Of Dermatomyositis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Polymyositis Market, Sub-Segmentation Of Inclusion Body Myositis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Polymyositis Market, Sub-Segmentation Of Overlapping Myositis Syndromes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Polymyositis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Polymyositis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global Polymyositis Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global Polymyositis Market - Company Scoring Matrix
  • Table 100: Pfizer Inc. Financial Performance
  • Table 101: F Hoffmann La Roche AG Financial Performance
  • Table 102: Bristol Myers Squibb Company Financial Performance
  • Table 103: AstraZeneca plc Financial Performance
  • Table 104: Novartis AG Financial Performance
  • Table 105: Global Polymyositis Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global Polymyositis Market, Competitive Dashboard
  • Table 107: Global Polymyositis Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, Polymyositis Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 109: Global, Polymyositis Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Table 110: Global, Polymyositis Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

List Of Figures

    Figure 1: Global Polymyositis Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Polymyositis Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Polymyositis Market, Supply Chain Analysis
  • Figure 4: Global Polymyositis Market, Major Raw Material Providers
  • Figure 5: Global Polymyositis Market, Major Resource Providers
  • Figure 6: Global Polymyositis Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Polymyositis Market, Major Distributors And Channel Partners
  • Figure 8: Global Polymyositis Market, Key Technologies & Future Trends
  • Figure 9: Global Polymyositis Market, Major Trends
  • Figure 10: Global Polymyositis Market, Major End Users
  • Figure 11: Global Polymyositis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Polymyositis Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Polymyositis Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Polymyositis Market - TAM, US$ Billion, 2025
  • Figure 15: Global Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Polymyositis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Polymyositis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Polymyositis Market, Sub-Segmentation Of Idiopathic Polymyositis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Polymyositis Market, Sub-Segmentation Of Dermatomyositis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Polymyositis Market, Sub-Segmentation Of Inclusion Body Myositis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Polymyositis Market, Sub-Segmentation Of Overlapping Myositis Syndromes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Polymyositis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Polymyositis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Polymyositis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Polymyositis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Polymyositis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global Polymyositis Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global Polymyositis Market - Company Scoring Matrix
  • Figure 100: Pfizer Inc. Financial Performance
  • Figure 101: F Hoffmann La Roche AG Financial Performance
  • Figure 102: Bristol Myers Squibb Company Financial Performance
  • Figure 103: AstraZeneca plc Financial Performance
  • Figure 104: Novartis AG Financial Performance
  • Figure 105: Global Polymyositis Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global Polymyositis Market, Competitive Dashboard
  • Figure 107: Global Polymyositis Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, Polymyositis Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 109: Global, Polymyositis Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Figure 110: Global, Polymyositis Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Pericarditis Market Report 2026 - Global Outlook – By Type (Acute Pericarditis, Chronic Pericarditis, Recurrent Pericarditis), By Diagnosis And Treatment (Electrocardiogram (ECG), Echocardiogram, Computerized Tomography ...

Interstitial Cystitis Market Report 2026 - Global Outlook – By Treatment (Medications, Bladder Instillation, Botulinum Toxin A, Nerve Stimulation, Surgery), By Patient Type (Pediatric Patients, Adult Patients), By Drug T...

Pheochromocytoma Market Report 2026 - Global Outlook – By Type (Adrenal Pheochromocytoma, Extra-Adrenal Pheochromocytoma), By Treatment (Medication, Surgery, Radionuclide Treatment, Other Treatments), By Diagnosis (Labor...

Emphysema Market Report 2026 - Global Outlook – By Type (Centrilobular, Panlobular), By Treatment (Medication, Therapy, Surgery, Other Treatments), By Diagnosis (Imaging Test, Lung Function Test, Other Diagnosis), By Com...

Non Hodgkin Lymphoma (NHL) Market Report 2026 - Global Outlook – By Type (B-Cell Lymphoma, T-Cell Lymphoma), By Treatment (Surgery, Stem Cell Transplant, Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy),...

Hydrocortisone Market Report 2026 - Global Outlook – By Type (Cream, Injection, Tablet), By Route Of Administration (Parenteral, Oral, Topical), By Application (Adrenocortical Dysfunction, Rheumatoid Arthritis, Dermatiti...

Nontuberculous Mycobacterial Infection Market Report 2026 - Global Outlook – By Drug Class (Macrolides, Rifampin, Aminoglycoside, Other Drug Classes), By Route Of Administration (Oral, Parenteral, Other Routes Of Adminis...

Alpha Mannosidosis Market 2022 - By Therapy Type (Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT)), By Indication (Type I, Type II, Type III), By End Use...

Frequently Asked Questions

The Polymyositis market was valued at $1.74 billion in 2025, increased to $1.85 billion in 2026, and is projected to reach $2.34 billion by 2030.

The global Polymyositis market is expected to grow at a CAGR of 6.0% from 2026 to 2035 to reach $2.34 billion by 2035.

Some Key Players in the Polymyositis market Include, Pfizer Inc., F Hoffmann La Roche AG, Bristol Myers Squibb Company, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Merck & Co. Inc., C H Boehringer Sohn AG & Co. KG, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Fresenius SE & Co. KGaA, UCB S.A., Teva Pharmaceuticals USA Inc., Kezar Life Sciences Inc., Argenx SE, Mallinckrodt Pharmaceuticals plc, Mitsubishi Tanabe Pharma Corporation, Sanofi S.A., AbbVie Inc., Eli Lilly and Company, Janssen Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., CSL Behring .

Major trend in this market includes: Advancements In Stem Cell Therapy For Autoimmune Diseases. For further insights on this market. request a sample here

North America was the largest region in the polymyositis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymyositis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us